170 related articles for article (PubMed ID: 16191862)
1. Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases.
Bracke A; Nijsten T; Vandermaesen J; Meuleman L; Lambert J
Acta Derm Venereol; 2005; 85(4):353-4. PubMed ID: 16191862
[No Abstract] [Full Text] [Related]
2. Lansoprazole--a new proton pump inhibitor.
Ahmed W; Ali A; Qureshi H; Zuberi SJ; Shamsi ZU
J Pak Med Assoc; 1995 May; 45(5):144-5. PubMed ID: 7563582
[No Abstract] [Full Text] [Related]
3. Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors.
Dam C; Bygum A
Acta Derm Venereol; 2008; 88(1):87-9. PubMed ID: 18176768
[No Abstract] [Full Text] [Related]
4. Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
Toms-Whittle LM; John LH; Buckley DA
Clin Exp Dermatol; 2011 Apr; 36(3):281-3. PubMed ID: 20738320
[TBL] [Abstract][Full Text] [Related]
5. Safety of lansoprazole.
Colin-Jones DG
Br J Clin Pract Suppl; 1994; 75():58-61; discussion 62-6. PubMed ID: 8060803
[No Abstract] [Full Text] [Related]
6. A difficult diagnosis: drug-induced subacute cutaneous lupus erythematosus (SCLE) triggered by omeprazole in a patient with pre-existing idiopathic SCLE.
Wee JS; Natkunarajah J; Marsden RA
Clin Exp Dermatol; 2012 Jun; 37(4):445-6. PubMed ID: 22420369
[No Abstract] [Full Text] [Related]
7. Lansoprazole-induced subacute cutaneous lupus erythematosus.
Panting KJ; Pinto M; Ellison J
Clin Exp Dermatol; 2009 Aug; 34(6):733-4. PubMed ID: 19508577
[No Abstract] [Full Text] [Related]
8. Lansoprazole: a cause of secretory diarrhea.
Goff JS
Am J Gastroenterol; 1998 Nov; 93(11):2298-9. PubMed ID: 9820425
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole: pharmacokinetics and pharmacodynamics.
Moules IK
Br J Clin Pract Suppl; 1994; 75():41-5; discussion 46-7. PubMed ID: 8060801
[No Abstract] [Full Text] [Related]
10. Omeprazole-induced subacute cutaneous lupus erythematosus.
Mankia SK; Rytina E; Burrows NP
Clin Exp Dermatol; 2010 Apr; 35(3):e1-2. PubMed ID: 20500156
[No Abstract] [Full Text] [Related]
11. Fatal toxic epidermal necrolysis due to lansoprazole.
Heaton NR; Edmonds EV; Francis ND; Bunker CB; Bowling JC; Morar N
Clin Exp Dermatol; 2004 Nov; 29(6):612-3. PubMed ID: 15550134
[TBL] [Abstract][Full Text] [Related]
12. Anti-Ro and anti-La antibody positive subacute cutaneous lupus erythematosus (SCLE) induced by lansoprazole.
McCourt C; Somerville J; McKenna K
Eur J Dermatol; 2010; 20(6):860-1. PubMed ID: 20974555
[No Abstract] [Full Text] [Related]
13. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors omeprazole and lansoprazole induce relaxation of isolated human arteries.
Naseri E; Yenisehirli A
Eur J Pharmacol; 2006 Feb; 531(1-3):226-31. PubMed ID: 16438963
[TBL] [Abstract][Full Text] [Related]
15. Lansoprazole-associated microscopic colitis: a case series.
Thomson RD; Lestina LS; Bensen SP; Toor A; Maheshwari Y; Ratcliffe NR
Am J Gastroenterol; 2002 Nov; 97(11):2908-13. PubMed ID: 12425567
[TBL] [Abstract][Full Text] [Related]
16. [Proton pump inhibitors].
Schubert-Zsilavecz M; Stark H
Pharm Unserer Zeit; 2005; 34(3):194-9. PubMed ID: 15940951
[No Abstract] [Full Text] [Related]
17. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
18. [Lupus erythematosus and proto-pump inhibitors].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2014 Mar; 141(3):252-3. PubMed ID: 24635967
[No Abstract] [Full Text] [Related]
19. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
[TBL] [Abstract][Full Text] [Related]
20. Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases.
Fumal I; Danchin A; Cosserat F; Barbaud A; Schmutz JL
Dermatology; 2005; 210(3):251-2. PubMed ID: 15785062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
